Release Date: 17/09/15 09:15 Summary: Presentation - Pointerra Pty Ltd Price Sensitive: No Download Document 5.92MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%